Metronidazole Injection

DRUG DESCRIPTION

Metronidazole (metronidazole (metronidazole injection) injection) Injection USP, sterile, is a parenteral dosage form of a synthetic antibacterial agent, 2-methyl-5-nitroimidazole-1-ethanol:

Metronidazole(metronidazole)   Structural Formula Illustration

Each 100 mL of Metronidazole (metronidazole (metronidazole injection) injection) Injection USP contains a sterile, nonpyrogenic, isotonic, buffered solution of Metronidazole (metronidazole (metronidazole injection) injection) USP 500 mg, Sodium Chloride USP 740 mg, Dibasic Sodium Phosphate•7H2O USP 112 mg, and Citric Acid Anhydrous USP 40 mg in Water for Injection USP. Metronidazole (metronidazole (metronidazole injection) injection) Injection USP has a calculated osmolarity of 297 mOsmol/liter and a pH of 5.8 (4.5–7.0). Sodium content: 13.5 mEq/container.

The PAB®

plastic container system is a copolymer of ethylene and propylene formulated and developed for parenteral drugs. The copolymer contains no plasticizers and exhibits virtually no leachability. The safety of the plastic container has been confirmed by biological evaluation procedures.

The material passes Class VI testing as specified in the U.S. Pharmacopeia for Biological Tests – Plastic Containers. These tests have shown that the container is nontoxic and biologically inert. The container-solution unit is a closed system and is not dependent upon entry of external air during administration. No overwrap is necessary.



Related Drugs Index: